# An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS

> **NCT05835518** · — · RECRUITING · sponsor: **Yuhan Corporation** · enrollment: 1000 (estimated)

## Conditions studied

- Rheumatoid Arthritis
- Ankylosing Spondylitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05835518
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-26
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-08
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2023-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05835518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05835518, "An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05835518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*